Bromodomain Inhibitor, (+)-JQ1

Details zu Produkt Nr. ABIN1304030, Anbieter: Anmelden zum Anzeigen
Blocking Reagent (BR), Inhibition Assay (InhA)
Anmelden zum Anzeigen
Hersteller Produkt- Nr.
Anmelden zum Anzeigen
Verwendungszweck A potent and highly specific BET inhibitor
Produktmerkmale A potent and highly specific inhibitor for the BET (bromodomain and extra-terminal) family of bromodomains. (+)-JQ1 binds to BRD4 bromodomains 1 and 2 with kDavalues of approx. 50 and 90 nM, respectively. The binding is competitive with acetyl lysine. (+)-JQ1 can be a useful chemical probe to investigate the role of BET bromodomains in the transcriptional regulation of oncogenesis.
Reinheit ≥ 98 % by HPLC
Chemical Name t-Butyl-2-((6S)-4-(4-chlorophenyl)-2,3,9-trimethyl-6H-thieno[3,2-f][1,2,4]triazolo[4,3-a][1,4]diazepin-6-yl)acetate
Formel C₂₃H₂₅ClN₄O₂S
Permeabilität Cell-permeable
Löslichkeit DMSO (10 mM)
Molekulargewicht 456.99 g/mol
CAS-Nummer 1268524-70-4
Beschränkungen Nur für Forschungszwecke einsetzbar
Format Solid
Handhabung Protect from air and moisture
Lagerung -20 °C
Haltbarkeit 24 months
Bilder des Herstellers
 image for Bromodomain Inhibitor, (+)-JQ1 (ABIN1304030) Bromodomain Inhibitor, (+)-JQ1
Produkt verwendet in: Gupta, Maetzig, Maertens, Sharif, Rothe, Weidner-Glunde, Galla, Schambach, Cherepanov, Schulz: "Bromo- and extraterminal domain chromatin regulators serve as cofactors for murine leukemia virus integration." in: Journal of virology, Vol. 87, Issue 23, pp. 12721-36, 2013 (PubMed).